Li Ying, Wang Yan
Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Tianjin Eye Hospital, Nankai University Eye Hospital, Tianjin 300020, China.
Chin Med Sci J. 2020 Mar 31;35(1):1-12. doi: 10.24920/003712.
Laser corneal refractive surgery has become an important treatment to correct ametropia in recent years. Rational medication in the perioperative period is essential to ensure the success of the surgery and to reduce complications. However, in this area there has been no consistent understanding and unified application guide across the world. Experts in Refractive Surgery Group, Ocular Microcirculation Branch of Chinese Society of Microcirculation who are specialized in keratology and optometry had initiated extensive and rigorous discussions and reached a consensus on appropriate medication before, during and after the refractive surgeries. The consensus covers a broad spectrum of commonly used ophthalmic solutions, provides recommendations of routine and enhanced medication on prevention and management of adverse reactions and complications related to the laser corneal refractive surgeries. We hope the consensus serves as a standard perioperative medication regimen for ophthalmologists, helps to ensure the safety and effectiveness of laser corneal refractive surgeries, and improves the quality and outcome of the refractive surgeries.
近年来，激光角膜屈光手术已成为矫正屈光不正的重要治疗方法。围手术期合理用药对于确保手术成功及减少并发症至关重要。然而，在这一领域，全球尚未形成一致的认识和统一的应用指南。中华微循环学会眼微循环分会屈光手术组中专门从事角膜病学和验光的专家们展开了广泛而严谨的讨论，并就屈光手术前、中、后的合理用药达成了共识。该共识涵盖了广泛的常用眼科制剂，针对与激光角膜屈光手术相关的不良反应和并发症的预防及处理，给出了常规用药和强化用药的建议。我们希望该共识能为眼科医生提供标准的围手术期用药方案，有助于确保激光角膜屈光手术的安全性和有效性，并提高屈光手术的质量和效果。
